Product Information
VENLAFAXINE HCL ER 150 MG CAP is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.1162 per EA under NDC 68382003616. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Apr 14, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382003616
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090174FDA Approved
4/14/2011
TE Code
AB
On Market Since
6/1/2011
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL ER 150 MG CAP has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 41.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1162 per EA |
|---|---|
| All-time high | $0.3504 (Mar 12, 2014) |
| All-time low | $0.1057 (Nov 20, 2024) |
| 52-week high | $0.1333 |
| 52-week low | $0.1152 |
| Median price | $0.1738 |
| Average price | $0.1725 |
| Largest weekly change | -32.5% (Apr 23, 2014) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL ER 150 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL ER 150 MG CAP, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.1162 per EA (NDC 68382003616), effective Aug 19, 2026.
How has the price of VENLAFAXINE HCL ER 150 MG CAP changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL ER 150 MG CAP has declined 41.9%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL ER 150 MG CAP?
Since Nov 28, 2013, the NADAC for VENLAFAXINE HCL ER 150 MG CAP has ranged from a low of $0.1057 (Nov 20, 2024) to a high of $0.3504 (Mar 12, 2014), with a median of $0.1738 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL ER 150 MG CAP?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as VENLAFAXINE HCL ER 150 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures VENLAFAXINE HCL ER 150 MG CAP?
VENLAFAXINE HCL ER 150 MG CAP (NDC 68382003616) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.